N. Khan, D.N. Syed u. a.: Fisetin: A Dietary Antioxidant for Health Promotion. In: Antioxid Redox Signal. Band19, Nr.2, 2013, S.151–162, doi:10.1089/ars.2012.4901, PMC 3689181 (freier Volltext).
V.M. Adhami u. a.: Dietary flavonoid fisetin: A novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management. In: Biochem Pharmacol. Band84, Nr.10, 2012, doi:10.1016/j.bcp.2012.07.012, PMC 3813433 (freier Volltext).
MJ Yousefzadeh u. a.: Fisetin is a senotherapeutic that extends health and lifespan. In: EBioMedicine. Nr.36, 2018, S.18–28, doi:10.1016/j.ebiom.2018.09.015, PMC 6197652 (freier Volltext).
Y. Zhu, EJ Doornebal u. a.: New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463. In: Aging (Albany NY). Band9, Nr.3, 2017, S.955–963, doi:10.18632/aging.101202, PMC 5391241 (freier Volltext).
N. Khan, D.N. Syed u. a.: Fisetin: A Dietary Antioxidant for Health Promotion. In: Antioxid Redox Signal. Band19, Nr.2, 2013, S.151–162, doi:10.1089/ars.2012.4901, PMC 3689181 (freier Volltext).
V.M. Adhami u. a.: Dietary flavonoid fisetin: A novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management. In: Biochem Pharmacol. Band84, Nr.10, 2012, doi:10.1016/j.bcp.2012.07.012, PMC 3813433 (freier Volltext).
MJ Yousefzadeh u. a.: Fisetin is a senotherapeutic that extends health and lifespan. In: EBioMedicine. Nr.36, 2018, S.18–28, doi:10.1016/j.ebiom.2018.09.015, PMC 6197652 (freier Volltext).
Y. Zhu, EJ Doornebal u. a.: New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463. In: Aging (Albany NY). Band9, Nr.3, 2017, S.955–963, doi:10.18632/aging.101202, PMC 5391241 (freier Volltext).